Dariohealth announces agreement with global employer for metabolic and musculoskeletal health solutions

New york, oct. 7, 2021 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced today an agreement with a global company based in the united states ("company") to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal (msk) health. the contract is expected to launch in the first quarter of 2022.
DRIO Ratings Summary
DRIO Quant Ranking